Beihai Gofar Chuanshan Biological Co., Ltd. - ROE
600538.SS
Price:
$4.79
Market Cap:
$2.51B
Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, engages in the distribution of pharmaceutical products in China. It operates through Pharmaceutical Distribution [Industry]; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails various medicines and medical devices through directly operated and franchised chain drugstores. It also provides pearl eye drops, pearl powder, and pearl layer powder under the Haibao brand; weichangning granules under the Guofa brand; ethanol disinfectant; honeysuckle mixture; feier syrup; medicinal wine for traumatic injury under the Hippocampus bran...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2003-01-14
Stock Exchange
SHH
Ticker
600538.SS
PE Ratio
[-26.49]
ROE
[-13.22%]
Current Ratio
[4.15]
Dividend Yield
[0%]
Enterprise Value
[2.45B]
Dividend History
The ROE as of October 2026 (TTM) for Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS) is -13.22%
According to Beihai Gofar Chuanshan Biological Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -13.22%. This represents a change of 289.26% compared to the average of -3.40% of the last 4 quarters.
Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS) Historical ROE (quarterly & annually)
How has 600538.SS ROE performed in the past?
The mean historical ROE of Beihai Gofar Chuanshan Biological Co., Ltd. over the last ten years is -3.52%. The current -13.22% ROE has changed 275.92% with respect to the historical average. Over the past ten years (40 quarters), 600538.SS's ROE was at its highest in in the December 2017 quarter at 2.84%. The ROE was at its lowest in in the December 2025 quarter at -12.18%.
Average
-3.52%
Median
-1.51%
Minimum
-12.74%
Maximum
3.66%
Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS) ROE by Quarter and Year
Discovering the peaks and valleys of Beihai Gofar Chuanshan Biological Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 220.08%
Maximum Annual ROE = 3.66%
Minimum Annual Increase = -924.64%
Minimum Annual ROE = -12.74%
| Year | ROE | Change |
|---|---|---|
| 2025 | -12.74% | 5.26% |
| 2024 | -12.10% | 27.82% |
| 2023 | -9.47% | -358.61% |
| 2022 | 3.66% | 220.08% |
| 2021 | 1.14% | 201.81% |
| 2020 | 0.38% | -57.61% |
| 2019 | 0.89% | -126.38% |
| 2018 | -3.39% | -352.45% |
| 2017 | 1.34% | -127.41% |
| 2016 | -4.90% | -924.64% |
Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS) Average ROE
How has 600538.SS ROE performed in the past?
The current ROE of Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-11.44%
5-year avg
-5.90%
10-year avg
-3.52%
Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS) ROE vs. Peers
How is 600538.SS’s ROE compared to its peers?
Beihai Gofar Chuanshan Biological Co., Ltd.’s ROE is greater than Jiangsu Flag Chemical Industry Co., Ltd. (-4.11%), greater than Anhui Liuguo Chemical Co., Ltd. (-30.75%), less than Dahu Health Industry Co., Ltd. (3.05%), less than Zhejiang XinNong Chemical Co.,Ltd. (8.55%), less than Shaanxi Meibang Pharmaceutical Group Co., Ltd. (5.44%), greater than Fanli Digital Technology Co.,Ltd (-14.98%), greater than Liuzhou Chemical Industry Co., Ltd. (-2.78%), greater than Hubei Shuanghuan Science and Technology Stock Co.,Ltd (-5.49%), less than Jiangsu Fengshan Group Co.,Ltd (1.69%), greater than Shandong Sino-Agri United Biotechnology Co., Ltd. Class A (-14.76%),
| Company | ROE | Market cap |
|---|---|---|
| -4.11% | $2.92B | |
| -30.75% | $2.84B | |
| 3.05% | $2.65B | |
| 8.55% | $2.65B | |
| 5.44% | $2.65B | |
| -14.98% | $4.22B | |
| -2.78% | $2.13B | |
| -5.49% | $2.70B | |
| 1.69% | $2.02B | |
| -14.76% | $2.05B |
Build a custom stock screener for Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Beihai Gofar Chuanshan Biological Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Beihai Gofar Chuanshan Biological Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Beihai Gofar Chuanshan Biological Co., Ltd.'s ROE?
How is the ROE calculated for Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS)?
What is the highest ROE for Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS)?
What is the 3-year average ROE for Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS)?
What is the 5-year average ROE for Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS)?
How does the current ROE for Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS) compare to its historical average?